• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析心血管疾病中的转录组。

Dissecting the transcriptome in cardiovascular disease.

机构信息

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Universiteitssingel 50, 6229 Maastricht University, Maastricht, The Netherlands.

The Division of Cardiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

出版信息

Cardiovasc Res. 2022 Mar 16;118(4):1004-1019. doi: 10.1093/cvr/cvab117.

DOI:10.1093/cvr/cvab117
PMID:33757121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8930073/
Abstract

The human transcriptome comprises a complex network of coding and non-coding RNAs implicated in a myriad of biological functions. Non-coding RNAs exhibit highly organized spatial and temporal expression patterns and are emerging as critical regulators of differentiation, homeostasis, and pathological states, including in the cardiovascular system. This review defines the current knowledge gaps, unmet methodological needs, and describes the challenges in dissecting and understanding the role and regulation of the non-coding transcriptome in cardiovascular disease. These challenges include poor annotation of the non-coding genome, determination of the cellular distribution of transcripts, assessment of the role of RNA processing and identification of cell-type specific changes in cardiovascular physiology and disease. We highlight similarities and differences in the hurdles associated with the analysis of the non-coding and protein-coding transcriptomes. In addition, we discuss how the lack of consensus and absence of standardized methods affect reproducibility of data. These shortcomings should be defeated in order to make significant scientific progress and foster the development of clinically applicable non-coding RNA-based therapeutic strategies to lessen the burden of cardiovascular disease.

摘要

人类转录组由编码和非编码 RNA 组成的复杂网络组成,这些 RNA 参与了多种生物学功能。非编码 RNA 表现出高度组织化的时空表达模式,并且作为分化、内稳态和病理状态(包括心血管系统)的关键调节剂而出现。本综述定义了当前的知识空白、未满足的方法学需求,并描述了在剖析和理解非编码转录组在心血管疾病中的作用和调控方面所面临的挑战。这些挑战包括非编码基因组注释不良、确定转录本的细胞分布、评估 RNA 加工的作用以及鉴定心血管生理学和疾病中细胞类型特异性的变化。我们强调了分析非编码和编码转录组所涉及的相似和不同的障碍。此外,我们还讨论了缺乏共识和缺乏标准化方法如何影响数据的可重复性。为了取得重大的科学进展并促进基于非编码 RNA 的治疗策略的临床应用,以减轻心血管疾病的负担,这些缺点应该得到克服。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/cebac82d7f19/cvab117f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/001846e25edc/cvab117f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/70cd20e262d6/cvab117f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/524039a74d99/cvab117f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/80d283f61822/cvab117f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/37f8ff701df5/cvab117f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/cebac82d7f19/cvab117f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/001846e25edc/cvab117f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/70cd20e262d6/cvab117f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/524039a74d99/cvab117f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/80d283f61822/cvab117f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/37f8ff701df5/cvab117f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5e/8930073/cebac82d7f19/cvab117f6.jpg

相似文献

1
Dissecting the transcriptome in cardiovascular disease.解析心血管疾病中的转录组。
Cardiovasc Res. 2022 Mar 16;118(4):1004-1019. doi: 10.1093/cvr/cvab117.
2
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association.非编码 RNA 在心血管疾病中的作用:当前的研究知识、工具和技术,以及未来的方向:美国心脏协会的科学声明。
Circ Genom Precis Med. 2020 Aug;13(4):e000062. doi: 10.1161/HCG.0000000000000062. Epub 2020 Jun 29.
3
Endothelial function and dysfunction in the cardiovascular system: the long non-coding road.心血管系统中的内皮功能和功能障碍:长非编码 RNA 的作用。
Cardiovasc Res. 2019 Oct 1;115(12):1692-1704. doi: 10.1093/cvr/cvz154.
4
Integrative transcriptome analysis suggest processing of a subset of long non-coding RNAs to small RNAs.整合转录组分析表明,一小部分长非编码 RNA 会被加工成小 RNA。
Biol Direct. 2012 Aug 7;7:25. doi: 10.1186/1745-6150-7-25.
5
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications.非编码 RNA 综述:从机制到治疗应用。
Biochem Pharmacol. 2024 Jun;224:116218. doi: 10.1016/j.bcp.2024.116218. Epub 2024 Apr 21.
6
Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system.N6-甲基腺苷调控因子与转录组的相关性:对发育和心血管系统的影响。
J Mol Cell Cardiol. 2021 Nov;160:56-70. doi: 10.1016/j.yjmcc.2021.05.006. Epub 2021 May 13.
7
Beyond the silence: A comprehensive exploration of long non-coding RNAs as genetic whispers and their essential regulatory functions in cardiovascular disorders.打破沉默:长链非编码RNA作为基因低语及其在心血管疾病中重要调控功能的全面探索
Curr Probl Cardiol. 2024 Mar;49(3):102390. doi: 10.1016/j.cpcardiol.2024.102390. Epub 2024 Jan 15.
8
Expedition to the missing link: Long noncoding RNAs in cardiovascular diseases.探索缺失环节:长非编码 RNA 在心血管疾病中的作用。
J Biomed Sci. 2020 Apr 2;27(1):48. doi: 10.1186/s12929-020-00647-w.
9
RNA (Epi)genetics in cardiovascular diseases.心血管疾病中的RNA(表观)遗传学
J Mol Cell Cardiol. 2015 Dec;89(Pt A):11-6. doi: 10.1016/j.yjmcc.2015.07.012. Epub 2015 Jul 20.
10
Strategies and challenges for non-viral delivery of non-coding RNAs to the heart.非编码RNA心脏非病毒递送的策略与挑战
Trends Mol Med. 2023 Jan;29(1):70-91. doi: 10.1016/j.molmed.2022.10.002. Epub 2022 Nov 9.

引用本文的文献

1
Adipose tissue gene expression and longitudinal clinical phenotypes are early biomarkers of lipid-regulating drug usage.脂肪组织基因表达和纵向临床表型是脂质调节药物使用的早期生物标志物。
Sci Rep. 2025 Aug 29;15(1):31861. doi: 10.1038/s41598-025-13693-x.
2
Circular RNA role in Atherosclerosis Development and Progression.环状RNA在动脉粥样硬化发生发展中的作用
Curr Atheroscler Rep. 2025 Jun 3;27(1):60. doi: 10.1007/s11883-025-01306-x.
3
Circular PVT1 promotes cardiac fibroblast activation interacting with miR-30a-5p and miR-125b-5p.

本文引用的文献

1
3D-cardiomics: A spatial transcriptional atlas of the mammalian heart.3D 心脏基因组学:哺乳动物心脏的空间转录组图谱。
J Mol Cell Cardiol. 2022 Feb;163:20-32. doi: 10.1016/j.yjmcc.2021.09.011. Epub 2021 Oct 5.
2
Divergent Transcription of the Locus Generates Two Enhancer RNAs with Opposing Functions.该基因座的差异转录产生了具有相反功能的两种增强子RNA。
iScience. 2020 Sep 6;23(9):101539. doi: 10.1016/j.isci.2020.101539. eCollection 2020 Sep 25.
3
When DNA gets in the way: A cautionary note for DNA contamination in extracellular RNA-seq studies.
环状PVT1通过与miR-30a-5p和miR-125b-5p相互作用促进心脏成纤维细胞活化。
Cell Death Dis. 2025 Apr 21;16(1):325. doi: 10.1038/s41419-025-07652-7.
4
Editorial: Traditional clinical symptoms and signs: how can they be used to investigate medications in the context of pharmacology?社论:传统临床症状和体征:在药理学背景下如何用于研究药物?
Front Pharmacol. 2025 Mar 31;16:1588000. doi: 10.3389/fphar.2025.1588000. eCollection 2025.
5
Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity.循环非编码RNA作为纤维化和心力衰竭严重程度的指标
Cells. 2025 Apr 7;14(7):553. doi: 10.3390/cells14070553.
6
The role of long non-coding RNAs in cardiovascular diseases: A comprehensive review.长链非编码RNA在心血管疾病中的作用:综述
Noncoding RNA Res. 2024 Dec 28;11:158-187. doi: 10.1016/j.ncrna.2024.12.009. eCollection 2025 Apr.
7
Pathophysiological insights into HFpEF from studies of human cardiac tissue.来自人体心脏组织研究的射血分数保留的心力衰竭病理生理学见解。
Nat Rev Cardiol. 2025 Feb;22(2):90-104. doi: 10.1038/s41569-024-01067-1. Epub 2024 Aug 28.
8
Relationship between LDL-cholesterol, small and dense LDL particles, and mRNA expression in a cohort of African Americans.非裔美国人队列中低密度脂蛋白胆固醇、小而密低密度脂蛋白颗粒与mRNA表达之间的关系。
Am J Physiol Heart Circ Physiol. 2024 Sep 1;327(3):H690-H700. doi: 10.1152/ajpheart.00332.2024. Epub 2024 Jul 19.
9
Coding and Non-Coding Transcriptomic Landscape of Aortic Complications in Marfan Syndrome.马凡综合征主动脉并发症的编码和非编码转录组景观。
Int J Mol Sci. 2024 Jul 5;25(13):7367. doi: 10.3390/ijms25137367.
10
Stressing the Circle: Circular RNA-LONP2 Role in Atherosclerosis.强调循环:环状RNA-LONP2在动脉粥样硬化中的作用
JACC Basic Transl Sci. 2024 May 27;9(5):671-673. doi: 10.1016/j.jacbts.2024.04.003. eCollection 2024 May.
当DNA成为阻碍:关于细胞外RNA测序研究中DNA污染的警示
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):18934-18936. doi: 10.1073/pnas.2001675117.
4
A long-read RNA-seq approach to identify novel transcripts of very large genes.一种长读 RNA-seq 方法,用于鉴定超大基因的新型转录本。
Genome Res. 2020 Jun;30(6):885-897. doi: 10.1101/gr.259903.119. Epub 2020 Jul 6.
5
Deconvolution of bulk blood eQTL effects into immune cell subpopulations.对血液 eQTL 效应进行批量反卷积到免疫细胞亚群。
BMC Bioinformatics. 2020 Jun 12;21(1):243. doi: 10.1186/s12859-020-03576-5.
6
Long-read human genome sequencing and its applications.长读长基因组测序及其应用。
Nat Rev Genet. 2020 Oct;21(10):597-614. doi: 10.1038/s41576-020-0236-x. Epub 2020 Jun 5.
7
Transcriptional and Cellular Diversity of the Human Heart.人类心脏的转录和细胞多样性。
Circulation. 2020 Aug 4;142(5):466-482. doi: 10.1161/CIRCULATIONAHA.119.045401. Epub 2020 May 14.
8
Dynamic Interstitial Cell Response during Myocardial Infarction Predicts Resilience to Rupture in Genetically Diverse Mice.心肌梗死后的动态间质细胞反应可预测遗传多样性小鼠对破裂的抵抗力。
Cell Rep. 2020 Mar 3;30(9):3149-3163.e6. doi: 10.1016/j.celrep.2020.02.008.
9
Systematic Comparison of High-throughput Single-Cell and Single-Nucleus Transcriptomes during Cardiomyocyte Differentiation.高通量单细胞和单核转录组在心肌细胞分化过程中的系统比较。
Sci Rep. 2020 Jan 30;10(1):1535. doi: 10.1038/s41598-020-58327-6.
10
Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function.单细胞重构人类心力衰竭和恢复过程中的心脏,揭示了心脏功能的细胞基础。
Nat Cell Biol. 2020 Jan;22(1):108-119. doi: 10.1038/s41556-019-0446-7. Epub 2020 Jan 8.